Un informe coordinado por Juan Bueren, investigador de la U710 CIBERER en el CIEMAT y el IIS-FJD, expone en términos divulgativos qué son las terapias génica y celular, presenta los principales ava...
Read moreSplice Bio, a biotech company based on technology developed in the Muir Lab at Princeton University, announced today a new investment into the Company led by Ysios Capital and joined by Asabys Partner...
Read moreThe IDIBELL group led by Dr. Julián Cerón has received an “Ideas Semilla” grant from the Spanish Association Against Cancer (AECC). These grants are addressed at innovative projects tha...
Read moreLa retinosis pigmentosa o pigmentaria es una enfermedad rara que se produce por un daño en unas importantes células de la retina que son los bastones. “El daño se produce por una mutación genét...
Read moreAs gene therapies move towards commercialization, a robust, scalable and affordable manufacturing process is critical to ensure these novel therapies reach the patient and that a pipeline of clinical ...
Read moreThe life science company Sartorius announced today it has entered into a definitive agreement to merge purification specialist BIA Separations into its subgroup Sartorius Stedim Biotech in a transacti...
Read moreUn equipo multidisciplinar formado por miembros de la U755 CIBERER en el Instituto de Investigación Sanitaria La Fe (IIS LaFe), la U733 CIBERER en la Universitat de València y la U739 CI...
Read more Gene therapies currently under study for retinal dystrophies are administered when viable photoreceptor able to be rescued at the functional level still remain. Most therapies are gene-specific...
Read moreSparingVision (“the Company”), a genomic medicine company focused on ocular diseases, today announces a €44.5 million financing round. The round was led by 4BIO Capital (“4BIO”) and UPMC Ent...
Read moreThe life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the ...
Read moreEl catedrático de la ETSI Informáticos de la UPM, Pedro Larrañaga, analiza el papel que jugará la inteligencia artificial en el desarrollo de la medicina en los próximos años en un debate online...
Read moreUn estudio dirigido por la Dra. Beatríz González Astorga, investigadora del grupo A01-TECNOLOGIA APLICADA A ONCOLOGIA Y TERAPIA GENICA del ibs.GRANADA en el Hospital Universitario Clínico San Ceci...
Read more